Nonmyeloablative allogeneic stem-cell transplantation for malignancy.
D054598:Blue Cross Blue Shield Insurance Plans; D017277:Drug Approval; D019317:Evidence-Based Medicine; D019337:Hematologic Neoplasms / Q000628:therapy*; D006801:Humans; D033581:Stem Cell Transplantation; D013673:Technology Assessment, Biomedical; D019172:Transplantation Conditioning; D014184:Transplantation, Homologous; D014481:United States; D014486:United States Food and Drug Administration